Search details
1.
Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
N Engl J Med
; 384(7): 630-642, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-33596357
2.
Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
Am J Obstet Gynecol
; 230(2): 237.e1-237.e11, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37863160
3.
Altered Extracellular Matrix-Related Pathways Accelerate the Transition from Normal to Pre-Fibroid Myometrium in Black Women.
Am J Obstet Gynecol
; 2024 May 31.
Article
in English
| MEDLINE | ID: mdl-38825029
4.
Fertility protection: a novel approach using pretreatment with mesenchymal stem cell exosomes to prevent chemotherapy-induced ovarian damage in a mouse model.
Am J Obstet Gynecol
; 2024 Feb 18.
Article
in English
| MEDLINE | ID: mdl-38378099
5.
Multiomic analysis of uterine leiomyomas in self-described Black and White women: molecular insights into health disparities.
Am J Obstet Gynecol
; 2024 May 07.
Article
in English
| MEDLINE | ID: mdl-38723985
6.
Developmental reprogramming of myometrial stem cells by endocrine disruptor linking to risk of uterine fibroids.
Cell Mol Life Sci
; 80(9): 274, 2023 Aug 31.
Article
in English
| MEDLINE | ID: mdl-37650943
7.
TGFß signaling links early life endocrine-disrupting chemicals exposure to suppression of nucleotide excision repair in rat myometrial stem cells.
Cell Mol Life Sci
; 80(10): 288, 2023 Sep 09.
Article
in English
| MEDLINE | ID: mdl-37689587
8.
Management of Uterine Fibroids and Sarcomas: The Palermo Position Paper.
Gynecol Obstet Invest
; 89(2): 73-86, 2024.
Article
in English
| MEDLINE | ID: mdl-38382486
9.
Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
Int J Mol Sci
; 25(2)2024 Jan 11.
Article
in English
| MEDLINE | ID: mdl-38255982
10.
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials.
Lancet
; 400(10356): 896-907, 2022 09 17.
Article
in English
| MEDLINE | ID: mdl-36116480
11.
Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids.
N Engl J Med
; 382(4): 328-340, 2020 01 23.
Article
in English
| MEDLINE | ID: mdl-31971678
12.
LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
Am J Obstet Gynecol
; 229(6): 662.e1-662.e25, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37666383
13.
Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Am J Obstet Gynecol
; 228(3): 320.e1-320.e11, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36370871
14.
Standardising outcome reporting for clinical trials of interventions for heavy menstrual bleeding: Development of a core outcome set.
BJOG
; 130(11): 1337-1345, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37055716
15.
The Functional Role and Regulatory Mechanism of FTO m6A RNA Demethylase in Human Uterine Leiomyosarcoma.
Int J Mol Sci
; 24(9)2023 Apr 27.
Article
in English
| MEDLINE | ID: mdl-37175660
16.
Update on the Role and Regulatory Mechanism of Extracellular Matrix in the Pathogenesis of Uterine Fibroids.
Int J Mol Sci
; 24(6)2023 Mar 17.
Article
in English
| MEDLINE | ID: mdl-36982852
17.
Epigenetic Modulation of Inflammatory Pathways in Myometrial Stem Cells and Risk of Uterine Fibroids.
Int J Mol Sci
; 24(14)2023 Jul 19.
Article
in English
| MEDLINE | ID: mdl-37511399
18.
Gene Expression Profile of Uterine Leiomyoma from Women Exposed to Different Air Pollution Levels in Metropolitan Cities of Sao Paulo, Brazil.
Int J Mol Sci
; 24(3)2023 Jan 26.
Article
in English
| MEDLINE | ID: mdl-36768749
19.
Therapeutic Potential of Mesenchymal Stem Cell-Derived Extracellular Vesicles to Treat PCOS.
Int J Mol Sci
; 24(13)2023 Jul 06.
Article
in English
| MEDLINE | ID: mdl-37446328
20.
Evidence-Based Approach for Secondary Prevention of Uterine Fibroids (The ESCAPE Approach).
Int J Mol Sci
; 24(21)2023 Nov 04.
Article
in English
| MEDLINE | ID: mdl-37958957